Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Sell
43
CL Quote, Financials, Valuation and Earnings
Last price:
$90.26
Seasonality move
:
-0.35%
Day range:
$90.09 - $93.05
52-week range:
$85.32 - $109.30
Dividend yield:
2.24%
P/E ratio:
25.50x
P/S ratio:
3.71x
P/B ratio:
201.51x
Volume:
5.3M
Avg. volume:
4.7M
1-year change:
-4.75%
Market cap:
$73.1B
Revenue:
$20.1B
EPS (TTM):
$3.54
Analysts' Opinion
-
Consensus RatingColgate-Palmolive has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 7 Buy ratings, 7 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $98.31, Colgate-Palmolive has an estimated upside of 8.92% from its current price of $90.26.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $84.18 representing 6.74% downside risk from its current price of $90.26.
Fair Value
-
According to the consensus of 15 analysts, Colgate-Palmolive has 8.92% upside to fair value with a price target of $98.31 per share.
CL vs. S&P 500
-
Over the past 5 trading days, Colgate-Palmolive has overperformed the S&P 500 by 0.41% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Colgate-Palmolive does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Colgate-Palmolive revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Colgate-Palmolive reported revenues of $4.9B.
Earnings Growth
-
Colgate-Palmolive has grown year-over-year earnings for 7 quarters straight. In the most recent quarter Colgate-Palmolive reported earnings per share of $0.85.
Enterprise value:
80.7B
EV / Invested capital:
--
Price / LTM sales:
3.71x
EV / EBIT:
19.12x
EV / Revenue:
4.04x
PEG ratio (5yr expected):
2.12x
EV / Free cash flow:
23.27x
Price / Operating cash flow:
21.36x
Enterprise value / EBITDA:
16.73x
Gross Profit (TTM):
$12.1B
Return On Assets:
17.55%
Net Income Margin (TTM):
14.52%
Return On Equity:
450.97%
Return On Invested Capital:
32.03%
Operating Margin:
21.91%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $18.3B | $19.8B | $19.9B | $5.1B | $4.9B | |
| Gross Profit | $10.4B | $11.7B | $12.1B | $3B | $3B | |
| Operating Income | $3.7B | $4.2B | $4.4B | $1B | $1.1B | |
| EBITDA | $3.4B | $4.4B | $4.8B | $1.2B | $1.2B | |
| Diluted EPS | $1.92 | $3.16 | $3.54 | $0.83 | $0.85 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.6B | $5B | $5.5B | $5.6B | $5.8B | |
| Total Assets | $15.8B | $15.7B | $16.2B | $16.6B | $16.6B | |
| Current Liabilities | $4.5B | $4.6B | $4.4B | $5.3B | $6.9B | |
| Total Liabilities | $15.1B | $15B | $15.7B | $16B | $15.9B | |
| Total Equity | $663M | $728M | $425M | $617M | $733M | |
| Total Debt | $7.8B | $7.6B | $8.9B | $8.7B | $8.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.9B | $3.7B | $4B | $681M | $600M | |
| Cash From Investing | -$1.7B | -$671M | -$500M | -$193M | -$159M | |
| Cash From Financing | -$1.1B | -$2.8B | -$3.5B | -$361M | -$458M | |
| Free Cash Flow | $2.2B | $3B | $3.5B | $555M | $476M | |
CL
Sector
Market Cap
$73.1B
$245.1M
Price % of 52-Week High
82.58%
75.15%
Dividend Yield
2.24%
0%
Shareholder Yield
4.2%
2.87%
1-Year Price Total Return
-4.75%
-10.48%
Beta (5-Year)
0.385
0.395
Dividend yield:
2.24%
Annualized payout:
$1.98
Payout ratio:
62.17%
Growth streak:
35 years
Technicals
8-day SMA
Sell
Level
$91.11
200-day SMA
Sell
Level
$93.91
Bollinger Bands (100)
Sell
Level
88.36 - 93.4
Chaikin Money Flow
Buy
Level
2.1B
20-day SMA
Sell
Level
$91.55
Relative Strength Index (RSI14)
Sell
Level
45.23
ADX Line
Sell
Level
8.58
Williams %R
Buy
Level
-80.0959
50-day SMA
Sell
Level
$91.72
MACD (12, 26)
Buy
Level
0.01
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
2.1B
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.2336)
Sell
CA Score
(Annual)
Level (-0.9769)
Buy
Beneish M-Score
(Annual)
Level (-2.8775)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (1.3988)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.
Stock Forecast FAQ
In the current month, CL has received 7 Buy ratings 7 Hold ratings, and 1 Sell ratings. The CL average analyst price target in the past 3 months is $98.31.
-
Where Will Colgate-Palmolive Stock Be In 1 Year?
According to analysts, the consensus estimate is that Colgate-Palmolive share price will rise to $98.31 per share over the next 12 months.
-
What Do Analysts Say About Colgate-Palmolive?
Analysts are divided on their view about Colgate-Palmolive share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Colgate-Palmolive is a Sell and believe this share price will drop from its current level to $84.18.
-
What Is Colgate-Palmolive's Price Target?
The price target for Colgate-Palmolive over the next 1-year time period is forecast to be $98.31 according to 15 Wall Street analysts, 7 of them rate the stock a Buy, 1 rates the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is CL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Colgate-Palmolive is a Leans Bullish. 7 of 15 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of CL?
You can purchase shares of Colgate-Palmolive via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Colgate-Palmolive shares.
-
What Is The Colgate-Palmolive Share Price Today?
Colgate-Palmolive was last trading at $90.26 per share. This represents the most recent stock quote for Colgate-Palmolive. Yesterday, Colgate-Palmolive closed at $90.26 per share.
-
How To Buy Colgate-Palmolive Stock Online?
In order to purchase Colgate-Palmolive stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TTD The Big Winner If Pharma Ads Are Banned?
Last week, Senators Bernie Sanders and Angus King introduced a…
Is Palantir Stock Overvalued?
By every traditional yardstick, including a price‑to‑sales well above 100,…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 48x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Sell
11
VEON alert for Jun 14
VEON [VEON] is down 18.57% over the past day.
Buy
74
DAVE alert for Jun 14
Dave [DAVE] is down 12.68% over the past day.
Buy
54
DAR alert for Jun 14
Darling Ingredients [DAR] is up 9.12% over the past day.
